Stein Schalkwijk

Twice-Yearly Depemokimab in Severe Asthma with an Eosinophilic Phenotype

David J. Jackson, Michael E. Wechsler, Daniel J. Jackson et al. · New England Journal of Medicine · 2024 · 121 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +16

Lowered Rilpivirine Exposure During the Third Trimester of Pregnancy in Human Immunodeficiency Virus Type 1–Infected Women

Stein Schalkwijk, Angela Colbers, Déborah Konopnicki et al. · Clinical Infectious Diseases · 2017 · 72 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +15

Importance of Prospective Studies in Pregnant and Breastfeeding Women Living With Human Immunodeficiency Virus

Angela Colbers, Mark Mirochnick, Stein Schalkwijk et al. · Clinical Infectious Diseases · 2019 · 70 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +16

Efficacy and safety of twice per year depemokimab in chronic rhinosinusitis with nasal polyps (ANCHOR-1 and ANCHOR-2): phase 3, randomised, double-blind, parallel trials

Philippe Gevaert, Martin Desrosiers, Marjolein Cornet et al. · The Lancet · 2025 · 70 citations

Medicine, Otolaryngology, Pharmacotherapy +8

Prediction of Fetal Darunavir Exposure by Integrating Human Ex-Vivo Placental Transfer and Physiologically Based Pharmacokinetic Modeling

Stein Schalkwijk, Aaron O. Buaben, Jolien J. M. Freriksen et al. · Clinical Pharmacokinetics · 2017 · 51 citations · Full text

Pharmacy, Obstetrics, Pharmacokinetics +16